The mammary stimulation test--a predictor of preterm delivery?
Clinical risk identification for preterm delivery, the major cause of perinatal morbidity and mortality, remains problematic. To test the hypothesis that a provocative test for uterine contractility at the beginning of the third trimester would reliably identify patients destined to be delivered before and at term, we designed the mammary stimulation test. Uterine contractions in response to nipple stimulation at a mean of 28.6 weeks' gestation, were evaluated in 94 gravid patients at risk for preterm delivery. The mammary stimulation test, the results of which were not used for clinical management, was positive in 50% of patients tested and had a sensitivity of 84% and a positive predictive value of 34% (chi 2 = 11.15, p less than 0.01). Ninety-four percent of patients predicted to be delivered at term actually were delivered at term (negative predictive value). Furthermore, no patients with a negative mammary stimulation test were delivered within 1 month of testing or were delivered of infants weighing less than 2000 gm. Discriminant analysis indicated that the mammary stimulation test provided information beyond that available from clinical risk factors alone. A cost analysis suggested that the use of the mammary stimulation test could reduce the cost of ambulatory uterine activity monitoring by nearly 50%. If these findings can be validated in additional samples, the mammary stimulation test may be useful in prematurity prevention programs.
Eden
R D
RD
Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan.
Sokol
R J
RJ
Sorokin
Y
Y
Cook
H J
HJ
Sheeran
G
G
Chik
L
L
D016002:Discriminant Analysis; D005260:Female; D005544:Forecasting; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D009558:Nipples / Q000502:physiology*; D010812:Physical Stimulation; D011237:Predictive Value of Tests; D011247:Pregnancy; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014590:Uterine Contraction